EDN
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EDN, covering 2025-09-22 to 2025-09-22. Get the full timeline:
Most recent: Clinical Trial Update: EDN Combined With TACE/HAIC and Second-Line Immune-Targeted Treatment Versus TACE/HAIC Alone in Locally Advanced HCC With Portal Vein Tumor Thrombosis After First-Line Therapy Failure: A Prospective, Multicenter, Randomized Controlled Trial [Phase 1, Phase 2]